Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Studies of Growth Deficiency and Growth Hormone Treatment in Children With Osteogenesis Imperfecta Types III and IV
NCT00001305Phase 3Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Nov 1991
- Primary completion
- May 2017
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in osteogenesis imperfecta (OI), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Nov 1991; status: completed.
02
Drugs
somatropin
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT00001305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001305.